EichorEICHOR
Location: Cairns Synced from ClinicalTrials.gov · August 09, 2026

Clinical studies recruiting near Cairns

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Resorbable Magnesium Scaffolds Registry
Phase N/A · Cairns Hospital · Biotronik AG · NCT04679740IMmune checkPoint Inhibitor Related gonAdal toxiCiTy in Premenopausal Women and Men With Melanoma
Phase N/A · Cairns Base Hospital · Peter MacCallum Cancer Centre, Australia · NCT07138222The National Australian HCV Point-of-Care Testing Program - Minimal Dataset
Phase N/A · Lotus Glen Correctional Centre · Kirby Institute · NCT05248555Guideline Oriented Approach To Lipid Lowering In Asia-Pacific
NA · Cairns & Hinterland Hospital & Health Service · Stephen Nicholls · NCT05325034Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)
NA · Cairns Hospital · The University of Queensland · NCT03573089Tiragolumab and Atezolizumab in Advanced Pan-cancer Patients
Phase 2 · Cairns Hospital · Omico · NCT06003621MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Phase 3 · Cairns Hospital · Intellia Therapeutics · NCT06128629ErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA Patients
Phase 3 · Cairns Hospital · Australian and New Zealand Intensive Care Research Centre · NCT04588311ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings
NA · Youthlink · Kirby Institute · NCT03685045Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Phase 3 · Research Site · AstraZeneca · NCT06307652Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for L
Phase 2/Phase 3 · Cairns Hospital · BioNTech SE · NCT06712316A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary
Phase 2 · Research Site · AstraZeneca · NCT07082738Atypical Hemolytic-Uremic Syndrome (aHUS) Registry
Phase N/A · Clinical Trial Site · Alexion Pharmaceuticals, Inc. · NCT01522183Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated S
Phase 3 · Cairns Hospital · BioNTech SE · NCT06712355Fibrinogen Early In Severe Trauma StudY II
Phase 3 · Cairns Hospital · Australian and New Zealand Intensive Care Research Centre · NCT05449834A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopul
Phase 3 · Research Site · AstraZeneca · NCT06283966Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Neg
Phase 3 · Cairns Hospital · Gilead Sciences · NCT05633654A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Meta
Phase 2 · Cairns Hospital · Regeneron Pharmaceuticals · NCT06769698Real World Assessment of People Living With Chronic Hepatitis B in Australia
Phase N/A · Cairns and Hinterland Hospital Health Service · Kirby Institute · NCT04914611Better Evidence and Translation for Calciphylaxis
Phase 3 · Cairns Hospital · University of Sydney · NCT05018221Staphylococcus Aureus Network Adaptive Platform Trial
Phase 4 · Cairns Hospital · University of Melbourne · NCT05137119Study of Intralesional FLD-103 in Subjects With Basal Cell Carcinoma (BCC)
Phase 1 · Feldan Therapeutics · NCT07670858Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator (ICD) Implantation to Prevent T
NA · Carins Hospital · Western Sydney Local Health District · NCT03588286INCremental Dialysis to Improve Health Outcomes in People Starting Haemodialysis (INCH-HD)
NA · Cairns Hospital · The University of Queensland · NCT04932148Duration of Anti-PD-1 Therapy in Metastatic Melanoma
Phase 3 · Cairns Hospital · Canadian Cancer Trials Group · NCT02821013The Australian HCV Point-of-Care Testing Program
Phase N/A · Cairns Sexual Health Service · Kirby Institute · NCT05042544Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (
Phase 2/Phase 3 · Cairns Hospital · CSL Behring · NCT05485961ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Phase 3 · Cairns Base Hospital · Novo Nordisk A/S · NCT06118281The National Australian HCV Point-of-Care Testing Program - HCV Antibody Testing Minimal Dataset
Phase N/A · Lotus Glen Correctional Centre · Kirby Institute · NCT05713136
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.